University of California San Diego
Dr. Carter is a Professor in the Department of Medicine and the Division of Genomics and Precision Medicine at UCSD. The Carter Lab develops and applies computational approaches to aid the interpretation of genetic variation and to advance precision cancer medicine. A major focus of the lab is on joint analysis of tumor and inherited genomes to uncover the role of genetic background in shaping cancer risk, somatic tumor evolution and therapeutic response. Her recent work investigates how the inherited immune system affects tumor genome evolution and the characteristics of the tumor immune microenvironment to identify opportunities and barriers for immunotherapy. Dr. Carter is a member of the UCSD Institute for Genomic Medicine, the Bioinformatics and Systems Biology Program and the Moores Cancer Center. She is an NIH Director’s Early Independence Awardee, a Mark Foundation Emerging Leader and Jaime Wyatt Miller Fellow, a CIFAR Azrieli Global Scholar and a Siebel Scholar.
Disclosure information not submitted.
Plenary II: Cancer Neoantigen Discovery from the HLA Perspective
Wednesday, October 23, 2024
10:30 AM – 12:00 PM US PDT
HLA Genotypes Shape the Cancer Mutation Landscape
Wednesday, October 23, 2024
10:31 AM – 10:55 AM US PDT